Objects of the Issue
| # | Purpose | Estimated Amount |
|---|---|---|
| 1 | Capacity expansion and upgradation of manufacturing facilities | ₹110.80 Cr |
| 2 | Establishment of a new R&D Centre; | ₹18.02 Cr |
| 3 | Repayment / prepayment of certain outstanding borrowings | ₹14.30 Cr |
| 4 | Working capital requirements | ₹33.00 Cr |
| 5 | Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia); and | ₹35.64 Cr |
| 6 | General corporate purposes | ₹44.74 Cr |
| 7 | Issue Expenses | ₹40.84 Cr |
| 8 | Total | ₹297.34 Cr |